Georgette’s LMR PMHNP Actual Certification Review 2026 – Psychiatric-Mental Health
NP COMPLETE QUESTIONS AND WELL DETAILED ANSWERS (VERIFIED) |
ALREADY GRADED A+||LATEST UPDATE 2026/27
Course
Georgette’s LMR PMHNP
1. A patient taking sertraline reports increased energy, decreased need for sleep, and racing
thoughts after several weeks of treatment. What is the PMHNP's priority?
A. Increase the sertraline dose
B. Assess for emerging mania/hypomania
C. Add another SSRI
D. Discontinue all psychiatric treatment permanently
Answer: B. Assess for emerging mania/hypomania
Rationale: Increased energy, decreased need for sleep, and racing thoughts can represent a
manic or hypomanic switch. The clinician should reassess the diagnosis, symptom severity,
safety, and medication regimen before making treatment changes.
2. Which finding most strongly supports a diagnosis of mania rather than hypomania?
A. Increased productivity without impairment
B. Elevated mood lasting several days without major consequences
C. Severe impairment requiring hospitalization
D. Mildly decreased need for sleep
Answer: C. Severe impairment requiring hospitalization
Rationale: Mania is more severe and can cause marked functional impairment, psychosis, or
require hospitalization. Hypomania is a less severe elevated/irritable state without marked
functional impairment or psychosis.
3. A patient taking lithium develops coarse tremor, vomiting, diarrhea, and confusion. What
should the PMHNP suspect?
A. Therapeutic response
B. Lithium toxicity
C. Serotonin deficiency
D. Anticholinergic syndrome
Answer: B. Lithium toxicity
,Rationale: Gastrointestinal symptoms, worsening tremor, ataxia, confusion, and neurologic
changes can indicate lithium toxicity. The medication should be evaluated urgently, including
serum lithium concentration and renal function as clinically appropriate.
4. Which factor can increase the risk of lithium toxicity?
A. Dehydration
B. Stable sodium intake
C. Adequate hydration
D. Consistent monitoring
Answer: A. Dehydration
Rationale: Lithium is renally cleared. Volume depletion can increase lithium concentration and
toxicity risk. Patients should receive education about maintaining consistent hydration and
promptly reporting significant vomiting, diarrhea, or other fluid losses.
5. Which laboratory parameter is particularly important when monitoring a patient taking
lithium?
A. Renal function
B. Amylase only
C. Hemoglobin A1c only
D. Serum iron only
Answer: A. Renal function
Rationale: Lithium is primarily eliminated through the kidneys. Renal impairment can increase
lithium exposure and toxicity risk, making renal monitoring clinically important.
6. A patient taking clozapine develops fever and sore throat. What is the priority concern?
A. Agranulocytosis
B. Mild dehydration
C. Akathisia
D. Tardive dyskinesia
Answer: A. Agranulocytosis
,Rationale: Clozapine can cause severe neutropenia/agranulocytosis. Fever or infection
symptoms require prompt evaluation and appropriate blood-count monitoring.
7. Which adverse effect is particularly associated with clozapine?
A. Agranulocytosis
B. Hyperthyroidism
C. Severe hearing loss
D. Cataracts in every patient
Answer: A. Agranulocytosis
Rationale: Clozapine has important risks including severe neutropenia, myocarditis, seizures,
metabolic effects, constipation, and others. Appropriate monitoring is essential.
8. A patient receiving an antipsychotic develops high fever, severe muscle rigidity, altered
consciousness, and autonomic instability. What condition is most likely?
A. Serotonin syndrome
B. Neuroleptic malignant syndrome
C. Panic disorder
D. Akathisia
Answer: B. Neuroleptic malignant syndrome
Rationale: NMS is a potentially life-threatening reaction characterized by severe rigidity,
hyperthermia, altered mental status, and autonomic instability, typically associated with
dopamine-blocking medications.
9. Which finding is more characteristic of serotonin syndrome than NMS?
A. Hyperreflexia and clonus
B. Severe lead-pipe rigidity
C. Markedly elevated creatine kinase alone
D. Dopamine antagonist exposure
Answer: A. Hyperreflexia and clonus
Rationale: Serotonin syndrome commonly features neuromuscular hyperactivity such as clonus,
hyperreflexia, tremor, and myoclonus, along with autonomic and mental-status changes.
, 10. A patient taking multiple serotonergic medications develops agitation, diaphoresis,
diarrhea, tremor, hyperreflexia, and clonus. What is the most likely diagnosis?
A. Serotonin syndrome
B. NMS
C. Anticholinergic toxicity
D. Lithium toxicity
Answer: A. Serotonin syndrome
Rationale: The combination of serotonergic exposure with autonomic symptoms and
neuromuscular hyperactivity strongly suggests serotonin toxicity.
11. Which medication class is generally considered first-line pharmacotherapy for PTSD?
A. SSRIs/SNRIs
B. Stimulants
C. Typical antipsychotics for every patient
D. Benzodiazepines as routine monotherapy
Answer: A. SSRIs/SNRIs
Rationale: Trauma-focused psychotherapy is central to PTSD treatment, while certain
SSRIs/SNRIs have evidence for pharmacologic management. Treatment should be individualized.
12. Which psychotherapy has strong evidence for PTSD?
A. Trauma-focused cognitive behavioral therapy
B. Psychoanalysis exclusively
C. Supportive conversation only
D. Aversion therapy
Answer: A
Rationale: Evidence-based trauma-focused approaches include therapies such as prolonged
exposure and cognitive processing therapy. Psychotherapy selection should consider patient
preference and clinical presentation.
NP COMPLETE QUESTIONS AND WELL DETAILED ANSWERS (VERIFIED) |
ALREADY GRADED A+||LATEST UPDATE 2026/27
Course
Georgette’s LMR PMHNP
1. A patient taking sertraline reports increased energy, decreased need for sleep, and racing
thoughts after several weeks of treatment. What is the PMHNP's priority?
A. Increase the sertraline dose
B. Assess for emerging mania/hypomania
C. Add another SSRI
D. Discontinue all psychiatric treatment permanently
Answer: B. Assess for emerging mania/hypomania
Rationale: Increased energy, decreased need for sleep, and racing thoughts can represent a
manic or hypomanic switch. The clinician should reassess the diagnosis, symptom severity,
safety, and medication regimen before making treatment changes.
2. Which finding most strongly supports a diagnosis of mania rather than hypomania?
A. Increased productivity without impairment
B. Elevated mood lasting several days without major consequences
C. Severe impairment requiring hospitalization
D. Mildly decreased need for sleep
Answer: C. Severe impairment requiring hospitalization
Rationale: Mania is more severe and can cause marked functional impairment, psychosis, or
require hospitalization. Hypomania is a less severe elevated/irritable state without marked
functional impairment or psychosis.
3. A patient taking lithium develops coarse tremor, vomiting, diarrhea, and confusion. What
should the PMHNP suspect?
A. Therapeutic response
B. Lithium toxicity
C. Serotonin deficiency
D. Anticholinergic syndrome
Answer: B. Lithium toxicity
,Rationale: Gastrointestinal symptoms, worsening tremor, ataxia, confusion, and neurologic
changes can indicate lithium toxicity. The medication should be evaluated urgently, including
serum lithium concentration and renal function as clinically appropriate.
4. Which factor can increase the risk of lithium toxicity?
A. Dehydration
B. Stable sodium intake
C. Adequate hydration
D. Consistent monitoring
Answer: A. Dehydration
Rationale: Lithium is renally cleared. Volume depletion can increase lithium concentration and
toxicity risk. Patients should receive education about maintaining consistent hydration and
promptly reporting significant vomiting, diarrhea, or other fluid losses.
5. Which laboratory parameter is particularly important when monitoring a patient taking
lithium?
A. Renal function
B. Amylase only
C. Hemoglobin A1c only
D. Serum iron only
Answer: A. Renal function
Rationale: Lithium is primarily eliminated through the kidneys. Renal impairment can increase
lithium exposure and toxicity risk, making renal monitoring clinically important.
6. A patient taking clozapine develops fever and sore throat. What is the priority concern?
A. Agranulocytosis
B. Mild dehydration
C. Akathisia
D. Tardive dyskinesia
Answer: A. Agranulocytosis
,Rationale: Clozapine can cause severe neutropenia/agranulocytosis. Fever or infection
symptoms require prompt evaluation and appropriate blood-count monitoring.
7. Which adverse effect is particularly associated with clozapine?
A. Agranulocytosis
B. Hyperthyroidism
C. Severe hearing loss
D. Cataracts in every patient
Answer: A. Agranulocytosis
Rationale: Clozapine has important risks including severe neutropenia, myocarditis, seizures,
metabolic effects, constipation, and others. Appropriate monitoring is essential.
8. A patient receiving an antipsychotic develops high fever, severe muscle rigidity, altered
consciousness, and autonomic instability. What condition is most likely?
A. Serotonin syndrome
B. Neuroleptic malignant syndrome
C. Panic disorder
D. Akathisia
Answer: B. Neuroleptic malignant syndrome
Rationale: NMS is a potentially life-threatening reaction characterized by severe rigidity,
hyperthermia, altered mental status, and autonomic instability, typically associated with
dopamine-blocking medications.
9. Which finding is more characteristic of serotonin syndrome than NMS?
A. Hyperreflexia and clonus
B. Severe lead-pipe rigidity
C. Markedly elevated creatine kinase alone
D. Dopamine antagonist exposure
Answer: A. Hyperreflexia and clonus
Rationale: Serotonin syndrome commonly features neuromuscular hyperactivity such as clonus,
hyperreflexia, tremor, and myoclonus, along with autonomic and mental-status changes.
, 10. A patient taking multiple serotonergic medications develops agitation, diaphoresis,
diarrhea, tremor, hyperreflexia, and clonus. What is the most likely diagnosis?
A. Serotonin syndrome
B. NMS
C. Anticholinergic toxicity
D. Lithium toxicity
Answer: A. Serotonin syndrome
Rationale: The combination of serotonergic exposure with autonomic symptoms and
neuromuscular hyperactivity strongly suggests serotonin toxicity.
11. Which medication class is generally considered first-line pharmacotherapy for PTSD?
A. SSRIs/SNRIs
B. Stimulants
C. Typical antipsychotics for every patient
D. Benzodiazepines as routine monotherapy
Answer: A. SSRIs/SNRIs
Rationale: Trauma-focused psychotherapy is central to PTSD treatment, while certain
SSRIs/SNRIs have evidence for pharmacologic management. Treatment should be individualized.
12. Which psychotherapy has strong evidence for PTSD?
A. Trauma-focused cognitive behavioral therapy
B. Psychoanalysis exclusively
C. Supportive conversation only
D. Aversion therapy
Answer: A
Rationale: Evidence-based trauma-focused approaches include therapies such as prolonged
exposure and cognitive processing therapy. Psychotherapy selection should consider patient
preference and clinical presentation.
